Biological Effective Radiation Dose for Multiple Myeloma Palliation

Biological Effective Radiation Dose for Multiple Myeloma Palliation

Purpose: Various radiation therapy (RT) dose/fractionation schedules are acceptable for palliation in multiple myeloma. Nine years of single-institution RT experience were reviewed to determine the influence of dose/fractionation and other factors pertinent to individualizing therapy. Methods and Ma...

Full description

Bibliographic Details
Main Authors:	Ruby F. Meredith, MD, PhD, John R. Bassler, MS, Andrew M. McDonald, MD, John M. Stahl, MD, David T. Redden, PhD, James A. Bonner, MD
Format:	Article
Language:	English
Published:	Elsevier 2023-07-01
Series:	Advances in Radiation Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S245210942300043X

Similar Items

Effective Pain Control With Very Low Dose Palliative Radiation Therapy for Patients With Multiple Myeloma With Uncomplicated Osseous Lesions
by: Jeremy G. Price, MD, PhD, et al.
Published: (2021-07-01)

Quality Indicators in Palliative Radiation Oncology: Development and Pilot Testing
by: Tetsuo Saito, MD, PhD, et al.
Published: (2022-03-01)

Palliative Radiation Therapy for Bone Metastases in Neuroendocrine Neoplasms
by: Michelle Guan, BS, et al.
Published: (2019-07-01)

Simulation-Free Radiation Therapy: An Emerging Form of Treatment Planning to Expedite Plan Generation for Patients Receiving Palliative Radiation Therapy
by: Joshua P. Schiff, MD, et al.
Published: (2023-01-01)

Variations Between Dose-Ventilation and Dose-Perfusion Metrics in Radiation Therapy Planning for Lung Cancer
by: Yujiro Nakajima, MS, et al.
Published: (2020-05-01)

Timing of Urgent Inpatient Palliative Radiation Therapy
by: Susan Y. Wu, MD, et al.
Published: (2021-05-01)

Comparison Between Dose-Escalated Intensity Modulated Radiation Therapy and 3-Dimensional Conformal Radiation Therapy for Salvage Radiation Therapy After Prostatectomy
by: Nana Shimoyachi, MD, et al.
Published: (2021-11-01)

Ovarian Transposition Before Pelvic Radiation Therapy: Spatial Distribution and Dose Volume Analysis
by: Christopher Gay, MD, et al.
Published: (2022-01-01)

Real-world Duration of Use and Dosing Frequency of Daratumumab in Patients With Multiple Myeloma in the United States
by: Rafael Fonseca, MD, et al.
Published: (2023-10-01)

Characteristics and Predictors of Radiographic Local Failure in Patients With Spinal Metastases Treated With Palliative Conventional Radiation Therapy
by: Jie Jane Chen, MD, et al.
Published: (2021-05-01)

Outcomes From Whole-Brain Reirradiation Using Pulsed Reduced Dose Rate Radiation Therapy
by: Adam R. Burr, MD, PhD, et al.
Published: (2020-09-01)

A Phase 2 Trial Combining Pembrolizumab and Palliative Radiation Therapy in Gastroesophageal Cancer to Augment Abscopal Immune Responses
by: Joseph Chao, MD, et al.
Published: (2022-01-01)

Systemic multiple myeloma and colonic abnormalities
by: Katarzyna M. Pawlak, MD, PhD, MRCPUK, et al.
Published: (2023-08-01)

Optimal Radiation Dose for Stage III Lung Cancer—Should “Definitive” Radiation Doses Be Used in the Preoperative Setting?
by: Areo G. Saffarzadeh, MD, MS, et al.
Published: (2021-08-01)

Lymphocyte Depletion Rate as a Biomarker of Radiation Dose to Circulating Lymphocytes During Fractionated Partial-Body Radiation Therapy
by: Susannah G. Ellsworth, MD, et al.
Published: (2022-09-01)

Fatigue in Patients With Head and Neck Cancer Treated With Radiation Therapy: A Prospective Study of Patient-Reported Outcomes and Their Association With Radiation Dose to the Cerebellum
by: Edvard Abel, MD, et al.
Published: (2022-09-01)

Serum cytokine profiles and metabolic tumor burden in patients with non-small cell lung cancer undergoing palliative thoracic radiation therapy
by: Hanne A. Eide, MD, et al.
Published: (2018-04-01)

Editorial: State of the Art CT and Image Quality, Radiation and Contrast Dose
by: Carlo Cavaliere MD, PhD
Published: (2021-12-01)

Effect of Target Changes on Target Coverage and Dose to the Normal Brain in Fractionated Stereotactic Radiation Therapy for Metastatic Brain Tumors
by: Hideharu Miura, PhD, et al.
Published: (2023-11-01)

Long-Term Risk of Hip Complications After Radiation Therapy for Prostate Cancer: A Dose-Response Study
by: Elisabeth Rasmusson, MD, et al.
Published: (2021-01-01)

An Analysis of Clinical Toxic Effects and Quality of Life as a Function of Radiation Dose and Volume After Lung Stereotactic Body Radiation Therapy
by: Suneetha Devpura, PhD, et al.
Published: (2021-11-01)

Dosimetric Modeling of Lymphopenia in Patients With Metastatic Cancer Receiving Palliative Radiation and PD-1 Immune Checkpoint Inhibitors
by: Jack M. Qian, MD, et al.
Published: (2022-03-01)

Brain Radiation Necrosis Outside the Target Volume After Proton Radiation Therapy: Analyses of Multiparametric Imaging and Proton Biologic Effectiveness
by: Julianna K. Bronk, MD, PhD, et al.
Published: (2022-11-01)

Novel Postoperative Hypofractionated Accelerated Radiation Dose-Painting Approach for Soft Tissue Sarcoma
by: Matthew Mills, MD, et al.
Published: (2024-03-01)

Radiation Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma: What Is the Right Regimen for Palliation?
by: Christopher M. Wright, MD, et al.
Published: (2022-11-01)

Impact of prone versus supine positioning on small bowel dose with pelvic intensity modulated radiation therapy
by: Victor J. Gonzalez, MD, et al.
Published: (2017-04-01)

Higher Dose Volumes May Be Better for Evaluating Radiation Pneumonitis in Lung Proton Therapy Patients Compared With Traditional Photon-Based Dose Constraints
by: Wendy B. Harris, PhD, et al.
Published: (2020-09-01)

Evaluation of Threshold Dose of Damaged Hepatic Tissue After Carbon-Ion Radiation Therapy Using Gd-EOB-DTPA–Enhanced Magnetic Resonance Imaging
by: Masashi Ebara, MD, et al.
Published: (2021-11-01)

Investigating the SPECT Dose-Function Metrics Associated With Radiation-Induced Lung Toxicity Risk in Patients With Non-small Cell Lung Cancer Undergoing Radiation Therapy
by: Daniel R. Owen, BS, et al.
Published: (2021-05-01)

Nonlinear Effects of Nanoparticles: Biological Variability from Hormetic Doses, Small Particle Sizes, and Dynamic Adaptive Interactions
by: Iris R. Bell MD PhD, et al.
Published: (2014-04-01)

Referral Practices of Cardiologists to Specialist Palliative Care in Canada
by: Michael J. Bonares, MD, et al.
Published: (2021-04-01)

Multiple myeloma presenting as cryoglobulinemic vasculitis
by: John S. Runge, PhD, et al.
Published: (2021-05-01)

Radiation Therapy for Plasma Cell Disease of the Brain and Skull: Poor Palliation and Survival After Treatment for Central Nervous System Involvement
by: Graeme R. Williams, MD, MBA, et al.
Published: (2021-07-01)

Long-Term Results of High-Dose 2-Fraction Carbon Ion Radiation Therapy for Hepatocellular Carcinoma
by: Shigeo Yasuda, MD, PhD, et al.
Published: (2020-03-01)

Feasibility of Dose Escalating [18F]fluciclovine Positron Emission Tomography Positive Pelvic Lymph Nodes During Moderately Hypofractionated Radiation Therapy for High-Risk Prostate Cancer
by: Andrew M. McDonald, MD, et al.
Published: (2019-10-01)

Comparison of Gonadal Toxicity of Single-Fraction Ultra-High Dose Rate and Conventional Radiation in Mice
by: Maria C. Cuitiño, DVM, PhD, et al.
Published: (2023-07-01)

Radiation Dose Sensitivity of Subregions of the Larynx to Patient-Reported Swallowing Outcomes
by: Mark D. Pepin, PhD, et al.
Published: (2024-05-01)

The virtual cone: A novel technique to generate spherical dose distributions using a multileaf collimator and standardized control-point sequence for small target radiation surgery
by: Richard A. Popple, PhD, et al.
Published: (2018-07-01)

Fractionated stereotactic radiation therapy for intact brain metastases
by: Samuel R. Marcrom, MD, et al.
Published: (2017-10-01)

Low-Dose Image-Guided Pediatric CNS Radiation Therapy: Final Analysis From a Prospective Low-Dose Cone-Beam CT Protocol From a Multinational Pediatrics Consortium
by: Sara R. Alcorn MD, MPH, PhD, et al.
Published: (2020-04-01)